14 Mar 2023

Third-Party Risk Management for Multinational Life Sciences Companies

This practice note discusses strategies for managing risks arising out of arrangements with third parties based in countries around the world for functions including distribution, sales and market acquisition, customs clearance, import/export processes, and license and permit applications.

Read now »


Related Content

Practical Guidance Updates
Featuring the latest updates from your Practical Guidance account.


Experience results today with practical guidance, legal research, and data-driven insights—all in one place.

Experience Lexis+